LAURUSLABS presents a compelling buy-side technical opportunity holding above pivot ₹975.5 support (S1 ₹937.1/S2 ₹913.4) near 200-SMA confluence after recent 5% correction from ₹1068 highs to ₹991.9 lows, signaling capitulation exhaustion with RSI(69.9) confirming bullish momentum restoration despite short-term MA resistance cluster. Strong Buy technical indicators (9/11 oscillators including CCI 82.8, ROC 5.97) alongside narrowing MACD validate downside depletion creating asymmetric risk-reward near S3 ₹875 zone, complemented by higher lows formation above key 962.93 weekly support. Attractive long entry targeting R1 ₹999.2/R2 ₹1037.6 breakout with tight stops below S2 ₹913.4 for optimal rebound capture in this pharma leader ahead of March expiry.
Warning-
Disclaimer– Registration granted by SEBI, membership of a SEBI recognized supervisory body (BSE) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Disclosure– Investments in securities market are subject to market risks, read all the related documents carefully before investing.